NCT07504458 2026-04-16
QUATRO-APL
Quetzal Therapeutics
Phase 3 Recruiting
Quetzal Therapeutics
First Affiliated Hospital of Zhejiang University
Kura Oncology, Inc.
AstraZeneca
Daiichi Sankyo
Karolinska University Hospital
Dana-Farber Cancer Institute
Novartis